Tarrytown, NY, United States of America

Raymond D Youssefyeh

This inventor holds 27 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Usv Pharmaceutical Corporation, Rorer Pharmaceutical Corporation, Rhone-Poulenc Rorer Pharmaceuticals Inc.. Active years: 1980-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raymond D Youssefyeh. Retrieved from https://idiyas.com/inventor/raymond-d-youssefyeh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.4

ph-index = 9

Forward Citations = 349(Granted Patents)


Location History:

  • Tarrytown, NY (US) (1980 - 1989)
  • Princeton Junchtion, NJ (US) (1989)
  • Princeton Junction, NJ (US) (1990 - 1994)
  • Princeton Junction,, NJ (US) (1994)

Company Filing History:


Years Active: 1980-1994

Loading Chart...
Loading Chart...
Areas of Expertise:
Antihypertensive Compounds
5-HT3 Antagonists
Dibenzofurancarboxamides
Aryl Ethers
Indole Quinoline
Azacyclic Bisphosphonates
Optically Pure Amides
Amino Acids
Anti-Allergic Compounds
Pharmaceutical Compositions
27 patents (USPTO):Explore Patents

Title: Raymond D Youssefyeh: A Pioneer in Pharmaceutical Innovation

Introduction

Raymond D Youssefyeh is a prominent inventor based in Tarrytown, New York, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 27 patents, Youssefyeh has focused on developing novel compounds and methods that advance medical science and improve treatment options for various health conditions.

Latest Patents

Some of his latest innovations include:

1. **Azacyclic bisphosphonates as anticholesterolemic agents** - This invention addresses the method of lowering abnormally high serum cholesterol levels without significantly reducing mevalonic metabolite synthesis. It introduces novel pharmacological formulations containing bisphosphonic acid and ester compounds that incorporate a cyclic ring linked to a bisphosphonate moiety, optimizing the therapeutic approach to managing cholesterol levels.

2. **2,6-methano-2H-1-benzoxocincarboxylic acids, esters and amides** - This patent presents unique compounds that exhibit 5-HT3 antagonist properties, beneficial in treating various central nervous system disorders. These compounds display unique antiemetic and gastric prokinetic activities, while avoiding any significant binding affinity to the D2 receptor. The associated methods of synthesis add to the advancement of treatment possibilities in this domain.

Career Highlights

Throughout his career, Youssefyeh has worked with esteemed organizations such as USV Pharmaceutical Corporation and Rorer Pharmaceutical Corporation. His experiences in these innovative companies have allowed him to merge his research and practical expertise in the pharmaceutical sector, further driving his success as an inventor.

Collaborations

Youssefyeh has collaborated with notable colleagues, including Howard Jones and Henry F Campbell. These collaborations have fostered an environment of shared knowledge and innovation, contributing to the advancements seen in his various patented works.

Conclusion

Raymond D Youssefyeh epitomizes the spirit of innovation in the pharmaceutical industry. Through his patented inventions and collaborative efforts, he continues to pave the way for breakthroughs in medical treatments, ensuring that his contributions positively impact patient care and health outcomes. His work exemplifies the importance of creativity and dedication in advancing the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…